Jul 2026
Integrative Molecular Docking and Dynamics Simulation for Repurposing FDA-Approved Drugs Against MGMT-Mediated Temozolomide Resistance in Glioblastoma
These three FDA-approved drugs represent promising MGMT inhibitor candidates that merit preclinical evaluation to overcome chemoresistance in glioblastoma.
Bowei Shen, Dan Qiao, Guanrun Qiao et al.
· Journal of Computational Bio... · 0 citations